Trade BSEM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
BioStem Technologies, Inc. (BSEM) is trading at US$2.47, down 6.44% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$63.12M. Over the past 52 weeks, BSEM has traded between US$2.25 and US$5.44. On Syfe you can trade BSEM with $0 commission and add it to your watchlist.
| Previous close | US$2.64 |
|---|---|
| Market cap | US$63.12M |
| 52-week range | US$2.25 – US$5.44 |
| Volume | 65.98K |
| Exchange | US |
BioStem Technologies, Inc.
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.
Year: 2008
BioStem Technologies, Inc. (BSEM) stock is trading at US$2.47, -6.44% from the previous close of US$2.64.
The market cap for BioStem Technologies, Inc. (BSEM) stock is approximately US$63.12M.
The 52-week high for BioStem Technologies, Inc. (BSEM) stock is US$5.44.
The 52-week low for BioStem Technologies, Inc. (BSEM) stock is US$2.25.
BioStem Technologies, Inc. (BSEM) does not currently pay a dividend.
Stay on top of BSEM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
